Lockheed Martin has returned to invest in Main Sequence Ventures’ second fundraise having previously committed to its Csiro-mandated first fund.

Australia-based venture capital firm Main Sequence Ventures secured A$250m ($194m) of capital commitments for its second fund yesterday, from investors including aerospace and defence manufacturer Lockheed Martin.

The fund’s other limited partners include Singaporean state-owned investment firm Temasek, superannuation fund HostPlus, venture capital firm Horizons Ventures and unspecified family offices and individual investors represented by Morgan Stanley Wealth Management and Mutual Trust.

Main Sequence was founded in 2017 to manage Csiro Innovation Fund 1, an investment vehicle established by research…